iBio, Inc. Lists on Nasdaq Stock Exchange
1 report, 1 independent
Updated Sep 23
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
iBio, Inc. is listed on the Nasdaq stock exchange. Equities research analysts at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for the company in a research note on September 17th. The consensus estimate for iBio’s current full-year earnings is ($0.39) per share.
From themarketsdaily.com
Why it matters
The company recently reported ($0.04) EPS for the quarter, which topped the consensus estimate of ($0.07) by $0.03. HC Wainwright holds a "Buy" rating and a $7.00 price objective on the stock.
From themarketsdaily.com
Who's involved
- NasdaqAmerican fully electronic stock exchange where iBio trades
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Legend Biotech and iBio are listed on the NASDAQ stock exchange.
- Ainos, Inc. listed its stock on the Nasdaq exchange on September 11, 2026.
- Xerox listed its shares on the Nasdaq stock exchange on September 23, 2026.
- SBC listed on the Nasdaq stock exchange on August 12, 2026.
- Sonos listed on the electronic stock exchange on September 2, 2026.